盐酸2-(氯甲基)吡嗪 | 210037-98-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 盐酸2-(氯甲基)吡嗪
• 英文名称: 2-(chloromethyl)pyrazine hydrochloride
• 英文别名: 2-(chloromethyl)pyrazine;hydrochloride
• CAS: 210037-98-2
• 化学式: C₅H₅ClN₂*ClH
• 分子量: 165.022
• InChiKey: AUUSNRMWSTXSAV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.64
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  25.8
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P260,P264,P270,P280,P301+P312+P330,P301+P330+P331,P303+P361+P353,P304+P340+P310,P305+P351+P338+P310,P362+P364,P405,P501
• 危险品运输编号：
  3261
• 危险性描述：
  H302+H312,H314

反应信息

• 作为反应物：
  描述：

  盐酸2-(氯甲基)吡嗪 、 硫脲 以 乙醇 为溶剂， 生成 2-Pyrazin-2-ylmethyl-isothiourea; hydrochloride
  参考文献：
  名称：

  Synthesis and antisecretory and antiulcer activities of derivatives and analogs of 2-(2-pyridyl)tetrahydrothiophene-2-carbothioamide

  摘要：

  New thioamide derivatives of 2-(2-pyridyl)tetrahydrothiophene-2-carbothioamide (29) and related compounds (in which the tetrahydrothiophene ring was replaced by tetrahydrothiopyran, tetrahydrofuran, 1,3-dithiane, or 1,3-oxathiane and where the pyridine ring was replaced by other nitrogen heterocycles) were synthesized and tested for their antisecretory and antiulcer activities. These thioamides were prepared according to one of the following methods: reaction of an isothiocyanate with the carbanion of the corresponding cyclic precursor (for secondary thioamides); reaction of ammonia or an amine with the dithio ester prepared from the same precursor (for primary, secondary, and tertiary thioamides). These thioamides were evaluated by the Shay method to measure their antisecretory activity and by the stress-induced-ulcer method to test their antiulcer activity. Structure-activity relationships are discussed. N-Methyl-2-(2-pyridyl)tetrahydrothiophene-2-carbothioamide (R.P. 40749, 30) exhibited activities that were at least 10 times higher than those reported for cimetidine.

  DOI：

  10.1021/jm00384a004

文献信息

• [EN] NEW AMINO-PYRIMIDONYL-PIPERIDINYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX DÉRIVÉS D'AMINO-PYRIMIDONYL-PIPÉRIDINYL, LEUR PROCÉDÉ DE PRÉPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：SERVIER LAB

  公开号：WO2020079205A1

  公开（公告）日：2020-04-23

  Compounds of formula (I) wherein R1, R2, R3, R4, R5, n and Q are as defined in the description. Medicaments.

  式(I)中R1、R2、R3、R4、R5、n和Q的化合物如描述中所定义。药物。
• COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS, METHOD OF SEPARATION, AND USE THEREOF
  申请人：Ustav organicke chemie a biochemie AV CR, v.v.i.

  公开号：EP3492460A1

  公开（公告）日：2019-06-05

  The present invention relates to the use of the compounds of general formula (I): wherein X, Y, Z, L, R and R1 are as described herein; for chromatographic separation of rare earth elements, as well as to the method of the separation of rare earth elements.

  本发明涉及通式（I）化合物的用途： 其中 X、Y、Z、L、R 和 R1 如本文所述； 以及分离稀土元素的方法。
• (Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
  申请人：LES LABORATOIRES SERVIER

  公开号：US10654849B2

  公开（公告）日：2020-05-19

  Compounds of formula (I): wherein R1, R2, J, K, L, n and W are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring pro-apoptotic and/or anti-proliferative agents.

  式(I)化合物： 其中 R1、R2、J、K、L、n 和 W 如说明中所定义。 含有相同成分的医药产品，可用于治疗需要促凋亡剂和/或抗增生剂的病症。
• INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE
  申请人：MERCK & CO., INC.

  公开号：EP0951285A1

  公开（公告）日：1999-10-27
• NEW (HETERO)ARYL-SUBSTITUTED-PIPERIDINYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：Les Laboratoires Servier

  公开号：EP3468971A1

  公开（公告）日：2019-04-17